These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 11938745)

  • 21. Effect of glucose tolerance status on PAI-1 plasma levels in overweight and obese subjects.
    Pannacciulli N; De Mitrio V; Marino R; Giorgino R; De Pergola G
    Obes Res; 2002 Aug; 10(8):717-25. PubMed ID: 12181379
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Plasma Lp (a) levels and correlation of Lp (a) with fibrinolysis activation in chronic renal failure].
    Zhu J; Xiong X; Zhao S; Wang Z; Lou L; Hang Q
    Hunan Yi Ke Da Xue Xue Bao; 1999; 24(4):366-8. PubMed ID: 12080650
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fibrinolytic dysfunction in insulin-resistant women with previous gestational diabetes.
    Farhan S; Winzer C; Tura A; Quehenberger P; Bieglmaier C; Wagner OF; Huber K; Waldhäusl W; Pacini G; Kautzky-Willer A
    Eur J Clin Invest; 2006 May; 36(5):345-52. PubMed ID: 16634839
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors affecting fibrinolytic potential: cardiovascular fitness, body composition, and lipoprotein(a).
    Szymanski LM; Durstine JL; Davis PG; Dowda M; Pate RR
    Metabolism; 1996 Nov; 45(11):1427-33. PubMed ID: 8931650
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of cilnidipine on lipids, lipoproteins and fibrinolytic system in hypertensive patients.
    Ahaneku JE; Sakata K; Uranol T; Takada Y; Takada A
    Drugs Exp Clin Res; 2000; 26(4):119-23. PubMed ID: 11109511
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fibrinolytic system in normotensive subjects and hypertensive patients.
    Armas-Hernández MJ; Hernández-Hernández R; Armas-Padilla MC; Sosa-Canache B; Cammarata R; Pacheco B; Guerrero-Pajuelo J; Israili ZH; Valasco M
    Am J Ther; 2007; 14(2):177-82. PubMed ID: 17414587
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Administration of antioxidant vitamins does not alter plasma fibrinolytic activity in subjects with central obesity.
    Rifici VA; Schneider SH; Chen Y; Khachadurian AK
    Thromb Haemost; 1997 Sep; 78(3):1111-4. PubMed ID: 9308762
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sex-related differences in the associations between hyperleptinemia, insulin resistance and dysfibrinolysis.
    Eriksson MA; Rask E; Johnson O; Carlström K; Ahrén B; Eliasson M; Boman K; Söderberg S
    Blood Coagul Fibrinolysis; 2008 Oct; 19(7):625-32. PubMed ID: 18832901
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tissue plasminogen activator (tPA) activity is a novel and early marker of asymptomatic LEAD in type 2 diabetes.
    Sahli D; Eriksson JW; Boman K; Svensson MK
    Thromb Res; 2009 Mar; 123(5):701-6. PubMed ID: 18945481
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Imbalance of plasminogen activator inhibitor-I/ tissue plasminogen activator and tissue factor/tissue factor pathway inhibitor in young Japanese men with myocardial infarction.
    Saigo M; Abe S; Ogawa M; Yamashita T; Biro S; Minagoe S; Maruyama I; Tei C
    Thromb Haemost; 2001 Nov; 86(5):1197-203. PubMed ID: 11816707
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of moderate weight loss on anginal symptoms and indices of coagulation and fibrinolysis in overweight patients with angina pectoris.
    Hankey CR; Lean ME; Lowe GD; Rumley A; Woodward M
    Eur J Clin Nutr; 2002 Oct; 56(10):1039-45. PubMed ID: 12373626
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fibrinolytic activity in Chinese patients with diabetes or hyperlipidemia in comparison with healthy controls.
    Ho CH; Jap TS
    Thromb Haemost; 1991 Jan; 65(1):3-6. PubMed ID: 1902595
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship of tissue plasminogen activator, plasminogen activator inhibitor-1 and fibrinogen with coronary artery disease in South Indian male subjects.
    Deepa R; Velmurugan K; Saravanan G; Dwarakanath V; Agarwal S; Mohan V
    J Assoc Physicians India; 2002 Jul; 50():901-6. PubMed ID: 12126344
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Eprosartan effect on fibrinolytic/hemostatic variables in arterial hypertension: a comparative study to losartan.
    Makris TK; Stavroulakis G; Papadopoulos DP; Krespi P; Hatzizacharias A; Zilidis A; Tsoukala C; Votteas VE
    Drugs Exp Clin Res; 2004; 30(3):125-32. PubMed ID: 15366789
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Tissue plasminogen activator (t-PA) and plasminogen activator inhibitor-1 (PAI-1) in children with ulcerative colitis].
    Grabarczyk E; Szaflarska-Popławska A; Góralczyk K; Rość D
    Pol Merkur Lekarski; 2006 Mar; 20(117):326-8. PubMed ID: 16780267
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhancement of fibrinolysis in poorly controlled, hospitalized type 2 diabetic patients by short-term metabolic control: association with a decrease in plasminogen activator inhibitor 1.
    Aso Y; Okumura KI; Yoshida N; Tayama K; Takemura Y; Inukai T
    Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):175-80. PubMed ID: 15127320
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hyperglycaemic siblings of Type II (non-insulin-dependent) diabetic patients have increased PAI-1, central obesity and insulin resistance compared with their paired normoglycaemic sibling.
    Herlihy OM; Barrow BA; Grant PJ; Levy JC
    Diabetologia; 2002 May; 45(5):635-41. PubMed ID: 12107743
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in leptin, plasminogen activator factor and oxidative stress in morbidly obese patients following open and laparoscopic Swedish adjustable gastric banding.
    Uzun H; Zengin K; Taskin M; Aydin S; Simsek G; Dariyerli N
    Obes Surg; 2004 May; 14(5):659-65. PubMed ID: 15186635
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of chromogenic substrate assays for fibrinolytic analytes in dogs.
    Lanevschi A; Kramer JW; Greene SA; Meyers KM
    Am J Vet Res; 1996 Aug; 57(8):1124-30. PubMed ID: 8836361
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of laparoscopic and conventional colorectal resection on peritoneal fibrinolytic capacity: a prospective randomized clinical trial.
    Neudecker J; Junghans T; Ziemer S; Raue W; Schwenk W
    Int J Colorectal Dis; 2002 Nov; 17(6):426-9. PubMed ID: 12355220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.